Wang S, Hu Y, Wang R, Zhang Y, Yuan Q, Yuan C
Curr Med Chem. 2024; 31(29):4687-4702.
PMID: 39081025
DOI: 10.2174/0109298673280484240101070607.
Loganathan T, C G
Funct Integr Genomics. 2023; 23(1):33.
PMID: 36625940
PMC: 9838419.
DOI: 10.1007/s10142-022-00947-4.
Dummer R, Vermeer M, Scarisbrick J, Kim Y, Stonesifer C, Tensen C
Nat Rev Dis Primers. 2021; 7(1):61.
PMID: 34446710
DOI: 10.1038/s41572-021-00296-9.
Song H, Liu Y, Liang H, Jin X, Liu L
Front Cell Dev Biol. 2021; 9:691140.
PMID: 34350182
PMC: 8326843.
DOI: 10.3389/fcell.2021.691140.
Lai P, Wang Y
Cancer Biol Med. 2021; 18(1):34-51.
PMID: 33628583
PMC: 7877166.
DOI: 10.20892/j.issn.2095-3941.2020.0216.
MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas.
Gluud M, Willerslev-Olsen A, Gjerdrum L, Lindahl L, Buus T, Andersen M
Cancers (Basel). 2020; 12(5).
PMID: 32414221
PMC: 7281391.
DOI: 10.3390/cancers12051229.
Integrated exome and RNA sequencing of dedifferentiated liposarcoma.
Hirata M, Asano N, Katayama K, Yoshida A, Tsuda Y, Sekimizu M
Nat Commun. 2019; 10(1):5683.
PMID: 31831742
PMC: 6908635.
DOI: 10.1038/s41467-019-13286-z.
MicroRNAs and Long Non-coding RNAs in Genetic Diseases.
Finotti A, Fabbri E, Lampronti I, Gasparello J, Borgatti M, Gambari R
Mol Diagn Ther. 2019; 23(2):155-171.
PMID: 30610665
PMC: 6469593.
DOI: 10.1007/s40291-018-0380-6.
PPAR Regulates the Proliferation of Human Glioma Cells through miR-214 and E2F2.
Gao Y, Han D, Sun L, Huang Q, Gai G, Wu Z
Biomed Res Int. 2018; 2018:3842753.
PMID: 29862267
PMC: 5976971.
DOI: 10.1155/2018/3842753.
MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential.
Fernandez-Mercado M, Manterola L, Lawrie C
Curr Genomics. 2016; 16(5):349-58.
PMID: 27047255
PMC: 4763973.
DOI: 10.2174/1389202916666150707160147.
Involvement of MicroRNA in T-Cell Differentiation and Malignancy.
Saki N, Abroun S, Soleimani M, Hajizamani S, Shahjahani M, Kast R
Int J Hematol Oncol Stem Cell Res. 2015; 9(1):33-49.
PMID: 25802699
PMC: 4369232.
MiRNAs in primary cutaneous lymphomas.
Yu X, Li Z, Liu J
Cell Prolif. 2015; 48(3):271-7.
PMID: 25736784
PMC: 6496498.
DOI: 10.1111/cpr.12179.
Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth.
Yin Y, Cai X, Chen X, Liang H, Zhang Y, Li J
Cell Res. 2014; 24(10):1164-80.
PMID: 25223704
PMC: 4185347.
DOI: 10.1038/cr.2014.121.
Evolution of the miR199-214 cluster and vertebrate skeletal development.
Desvignes T, Contreras A, Postlethwait J
RNA Biol. 2014; 11(4):281-94.
PMID: 24643020
PMC: 4075512.
DOI: 10.4161/rna.28141.
Dysregulation of microRNAs and their association in the pathogenesis of T-cell lymphoma/leukemias.
Ikeda S, Tagawa H
Int J Hematol. 2014; 99(5):542-52.
PMID: 24567260
DOI: 10.1007/s12185-014-1535-9.
MicroRNA profiling of primary cutaneous large B-cell lymphomas.
Koens L, Qin Y, Leung W, Corver W, Jansen P, Willemze R
PLoS One. 2013; 8(12):e82471.
PMID: 24358187
PMC: 3865085.
DOI: 10.1371/journal.pone.0082471.
miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma.
McGirt L, Adams C, Baerenwald D, Zwerner J, Zic J, Eischen C
J Invest Dermatol. 2013; 134(4):1101-1107.
PMID: 24304814
PMC: 3961555.
DOI: 10.1038/jid.2013.461.
The role of molecular pathology in the diagnosis of cutaneous lymphomas.
Raess P, Bagg A
Patholog Res Int. 2012; 2012:913523.
PMID: 23213624
PMC: 3506916.
DOI: 10.1155/2012/913523.
